• 2025 TSOC Consensus on the Clinical Pathway of Blood Cholesterol Management in Taiwan
  [2025臺灣高血脂治療共識]

• 2022 TSOC Taiwan Lipid Guidelines for Primary Prevention
  [2022臺灣高血脂治療指引1]

• 2022 TSOC Focused Update of the Taiwan Lipid Guidelines for High Risk Patients
  [2022臺灣高血脂治療指引2]

• 2017 TSOC Taiwan Lipid Guidelines for High Risk Patients
  [2017臺灣高血脂治療指引]

美國高血脂治療指引

• 2018 ACC/AHA Guideline on the Management of Blood Cholesterol
  [2018美國高血脂治療指引]

• 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
  [2013美國高血脂治療指引]

歐洲高血脂治療指引

• 2025 ESC Focused Update of the Guidelines for the Management of Dyslipidaemias
  [2025歐洲高血脂治療指引]

• 2019 ESC Guidelines for the Management of Dyslipidaemias
  [2019歐洲高血脂治療指引]

• 2016 ESC Guidelines for the Management of Dyslipidaemias
  [2016歐洲高血脂治療指引]

• 2011 ESC Guidelines for the Management of Dyslipidaemias
  [2011歐洲高血脂治療指引]

• 2025 TMASO Evidence-Based Guideline on Adult Obesity in Taiwan
  [2025臺灣成人肥胖臨床實證指引]

• 2023 TMASO Evidences-Based Guideline on Adult Obesity Prevention and Management
  [2023臺灣成人肥胖防治實證指引]

• 2019 TPA Evidences-Based Guideline on Children Obesity Prevention and Management
  [2019臺灣兒童肥胖防治實證指引]

美國肥胖症治療指引

• 2025 ACC Concise Clinical Guidance: An Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health
  [2025美國肥胖症治療指引]

• 2013 ACC/AHA Guideline for the Management of Overweight and Obesity in Adults
  [2013美國肥胖症治療指引]

歐洲肥胖症治療指引

• 2026 NICE Overweight and Obesity Management
  [2026英國肥胖症治療指引]